The global PARP Inhibitor Market is estimated to be valued at US$ 6.13 Bn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
SWOT Analysis
Strength: Parp inhibitor drugs have shown promising results in clinical trials for breast cancer and ovarian cancer...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian